[The characteristics of the treatment of newly detected pulmonary tuberculosis in miners]. 1996

N I Fomicheva, and I F Magaletskiĭ, and N V Ogiĭ, and L V Sazonova

Results are submitted on the treatment of 192 miners free from manifest signs of silicosis when they first presented with different forms of pulmonary tuberculosis. Tuberculosis in those individuals engaged in the coal industry was found out to poorly respond to treatment. During the period of 1.5-2 years, cicatrization of the cavities of decay occurred in 42.6 percent of the cases, no bacteria were recoverable in 50.0 percent. The treatment results were dependent upon the utilization of combinations of antituberculous drug preparations, routes of their administration and choice of pathogenetic options. The greatest benefit from treatment occurred with izoniazid, rifampicin, ethambutol and intrabronchial instillations of izoniazid.

UI MeSH Term Description Entries
D009784 Occupational Diseases Diseases caused by factors involved in one's employment. Diseases, Occupational,Occupational Illnesses,Disease, Occupational,Illnesse, Occupational,Illnesses, Occupational,Occupational Disease,Occupational Illnesse
D011013 Pneumonectomy The excision of lung tissue including partial or total lung lobectomy. Bronchoscopic Lung Volume Reduction,Endoscopic Lung Volume Reduction,Lung Volume Reduction,Lung Volume Reduction Surgery,Partial Pneumonectomy,Partial Pneumonectomies,Pneumonectomies,Pneumonectomy, Partial,Reduction, Lung Volume,Volume Reduction, Lung
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D003032 Coal Mining The practice of extracting COAL from the earth. Mining, Coal
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

N I Fomicheva, and I F Magaletskiĭ, and N V Ogiĭ, and L V Sazonova
October 1980, Vrachebnoe delo,
N I Fomicheva, and I F Magaletskiĭ, and N V Ogiĭ, and L V Sazonova
January 1986, Problemy tuberkuleza,
N I Fomicheva, and I F Magaletskiĭ, and N V Ogiĭ, and L V Sazonova
January 1987, Problemy tuberkuleza,
N I Fomicheva, and I F Magaletskiĭ, and N V Ogiĭ, and L V Sazonova
January 1974, Problemy tuberkuleza,
N I Fomicheva, and I F Magaletskiĭ, and N V Ogiĭ, and L V Sazonova
May 1981, Vrachebnoe delo,
N I Fomicheva, and I F Magaletskiĭ, and N V Ogiĭ, and L V Sazonova
July 1976, Problemy tuberkuleza,
N I Fomicheva, and I F Magaletskiĭ, and N V Ogiĭ, and L V Sazonova
June 1978, Problemy tuberkuleza,
N I Fomicheva, and I F Magaletskiĭ, and N V Ogiĭ, and L V Sazonova
August 1980, Problemy tuberkuleza,
N I Fomicheva, and I F Magaletskiĭ, and N V Ogiĭ, and L V Sazonova
October 1978, Problemy tuberkuleza,
N I Fomicheva, and I F Magaletskiĭ, and N V Ogiĭ, and L V Sazonova
January 1975, Problemy tuberkuleza,
Copied contents to your clipboard!